PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Nov-2020 ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution ENPICOM
05-Nov-2020 EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2020 ON 12 NOVEMBER 2020 Evotec SE
05-Nov-2020 Genmab Announces Financial Results for the First Nine Months of 2020 Genmab
05-Nov-2020 Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Subcutaneous Formulation for the Treatment of Patients with Light Chain (AL) Amyloidosis Janssen
05-Nov-2020 GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth Envision Pharma Group
05-Nov-2020 Hikma continues strong 2020 performance and updates full year guidance Hikma
05-Nov-2020 New £2.5m Influenza Challenge Study Contract Win Open Orphan plc (ORPH)
05-Nov-2020 The New Power of the Pharmaceutical Industry: Covid-19 Vaccines and the Social Responsibility of Pharmaceutical Companies Institute for Business Ethics and Sustainable Strategy (IBES)
05-Nov-2020 Lynparza approved in the EU for the treatment of BRCA- mutated metastatic castration-resistant prostate cancer AstraZeneca
05-Nov-2020 Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer AstraZeneca
05-Nov-2020 ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences B3C newswire
05-Nov-2020 MetrioPharm AG: MetrioPharm Announces Publication of Successful MP1032 Preclinical Data in COVID-19 MetrioPharm AG
05-Nov-2020 Forxiga approved in the EU for heart failure AstraZeneca
05-Nov-2020 Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With Cystic Fibrosis as Early as Four Months of Age Vertex
05-Nov-2020 Tacalyx Appoints Dr. Klaus Schollmeier as Chairman of the Board Tacalyx GmbH
05-Nov-2020 Relief Therapeutics and NeuroRx announce continuation of RLF-100(TM) trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020 RELIEF THERAPEUTICS Holdings AG
05-Nov-2020 STRATEC WITH DOUBLE-DIGIT GROWTH IN SALES AND EARNINGS IN FIRST NINE MONTHS OF 2020 STRATEC SE
04-Nov-2020 MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition MorphoSys AG
04-Nov-2020 Invitation to MorphoSys' Third Quarter and First 9-Month 2020 Results Conference Call on November 12, 2020 MorphoSys AG
04-Nov-2020 UBC, a Provider of Comprehensive and Integrated Care Programs, Announces Enhanced In-Workflow Services to Ease Enrollment into Patient Support Programs United BioSource Corporation